SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Sun Xiujuan) "

Sökning: WFRF:(Sun Xiujuan)

  • Resultat 1-10 av 25
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Fang, Zhiyong, et al. (författare)
  • Selective Electro-oxidation of Alcohols to the Corresponding Aldehydes in Aqueous Solution via Cu(III) Intermediates from CuO Nanorods
  • 2021
  • Ingår i: ACS Sustainable Chemistry and Engineering. - : American Chemical Society (ACS). - 2168-0485. ; 9:35, s. 11855-11861
  • Tidskriftsartikel (refereegranskat)abstract
    • Electrochemical oxidation using renewable energy is an attractive strategy that provides a sustainable and mild approach for biomass transformation. Herein, the electrocatalytic oxidation of furfuryl alcohol in an aqueous solution was investigated using CuO nanorods. Two kinds of Cu-III intermediates, namely, (CuO2)(-) and (Cu2O6)(6-), were detected on the surface of the working electrode. (Cu2O6)(6-), generated in the potential range of 1.35-1.39 V versus the reversible hydrogen electrode (RHE), induced the oxidation of furfuryl alcohol to furaldehyde with a yield of >= 98%. (CuO2)(-), generated at a potential greater than 1.39 V versus RHE, which led to the oxidation of furfuryl alcohol to 2-furoic acid with a yield of >= 99%. Furthermore, the Cu-III-catalyzed system exhibited a measure of universal applicability, wherein (Cu2O6)(6-) and (CuO2)(-) induced the highly selective electro-oxidation of benzyl alcohol, vanillyl alcohol, and 4-pyridinemethanol to yield the corresponding aldehydes and acids, respectively.
  •  
3.
  • Geyer, Holly L., et al. (författare)
  • Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms : an analysis by the MPN QOL International Working Group
  • 2017
  • Ingår i: Haematologica. - : Ferrata Storti Foundation (Haematologica). - 0390-6078 .- 1592-8721. ; 102:1, s. 85-93
  • Tidskriftsartikel (refereegranskat)abstract
    • The myeloproliferative neoplasms, including polycythemia vera, essential thrombocythemia and myelofibrosis, are distinguished by their debilitating symptom profiles, life-threatening complications and profound impact on quality of life. The role gender plays in the symptomatology of myeloproliferative neoplasms remains under-investigated. In this study we evaluated how gender relates to patients' characteristics, disease complications and overall symptom expression. A total of 2,006 patients (polycythemia vera=711, essential thrombocythemia=830, myelofibrosis=460, unknown=5) were prospectively evaluated, with patients completing the Myeloproliferative Neoplasm-Symptom Assessment Form and Brief Fatigue Inventory Patient Reported Outcome tools. Information on the individual patients' characteristics, disease complications and laboratory data was collected. Consistent with known literature, most female patients were more likely to have essential thrombocythemia (48.6% versus 33.0%; P<0.001) and most male patients were more likely to have polycythemia vera (41.8% versus 30.3%; P<0.001). The rate of thrombocytopenia was higher among males than females (13.9% versus 8.2%; P<0.001) and males also had greater red-blood cell transfusion requirements (7.3% versus 4.9%; P=0.02) with shorter mean disease duration (6.4 versus 7.2 years, P=0.03). Despite there being no statistical differences in risk scores, receipt of most therapies or prior complications (hemorrhage, thrombosis), females had more severe and more frequent symptoms for most individual symptoms, along with overall total symptom score (22.8 versus 20.3; P<0.001). Females had particularly high scores for abdominal-related symptoms (abdominal pain/discomfort) and microvascular symptoms (headache, fatigue, insomnia, concentration difficulties, dizziness; all P<0.01). Despite complaining of more severe symptom burden, females had similar quality of life scores to those of males. The results of this study suggest that gender contributes to the heterogeneity of myeloproliferative neoplasms by influencing phenotypic profiles and symptom expression.
  •  
4.
  •  
5.
  •  
6.
  • Geyer, Holly, et al. (författare)
  • Symptomatic Profiles of Patients With Polycythemia Vera : Implications of Inadequately Controlled Disease
  • 2016
  • Ingår i: Journal of Clinical Oncology. - 0732-183X .- 1527-7755. ; 34:2, s. 151-
  • Tidskriftsartikel (refereegranskat)abstract
    • PURPOSE: Polycythemia vera (PV) is a myeloproliferative neoplasm (MPN) associated with disabling symptoms and a heightened risk of life-threatening complications. Recent studies have demonstrated the effectiveness of JAK inhibitor therapy in patients with PV patients who have a history of prior hydroxyurea (HU) use (including resistance or intolerance), phlebotomy requirements, and palpable splenomegaly. We aimed to determine how these features contribute alone and in aggregate to the PV symptom burden.PATIENTS AND METHODS: Through prospective evaluation of 1,334 patients with PV who had characterized symptom burden, we assessed patient demographics, laboratory data, and the presence of splenomegaly by disease feature (ie, known HU use, known phlebotomy requirements, splenomegaly).RESULTS: The presence of each feature in itself is associated with a moderately high symptom burden (MPN symptom assessment form [SAF] total symptom score [TSS] range, 27.7 to 29.2) that persists independent of PV risk category. In addition, symptoms incrementally increase in severity with the addition of other features. Patients with PV who had all three features (PV-HUPS) faced the highest total score (MPN-SAF TSS, 32.5) but had similar individual symptom scores to patients with known HU use (PV-HU), known phlebotomy (PV-P), and splenomegaly (PV-S).CONCLUSION: The results of this study suggest that patients with PV who have any one of the features in question (known HU use, known phlebotomy, or splenomegaly) have significant PV-associated symptoms. Furthermore, it demonstrates that many PV symptoms remain severe independent of the number of features present.
  •  
7.
  • Hayashi, Makoto, et al. (författare)
  • VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formation
  • 2013
  • Ingår i: Nature Communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 4, s. 1672-
  • Tidskriftsartikel (refereegranskat)abstract
    • Vascular endothelial growth factor (VEGF) guides the path of new vessel sprouts by inducing VEGF receptor-2 activity in the sprout tip. In the stalk cells of the sprout, VEGF receptor-2 activity is downregulated. Here, we show that VEGF receptor-2 in stalk cells is dephosphorylated by the endothelium-specific vascular endothelial-phosphotyrosine phosphatase (VE-PTP). VE-PTP acts on VEGF receptor-2 located in endothelial junctions indirectly, via the Angiopoietin-1 receptor Tie2. VE-PTP inactivation in mouse embryoid bodies leads to excess VEGF receptor-2 activity in stalk cells, increased tyrosine phosphorylation of VE-cadherin and loss of cell polarity and lumen formation. Vessels in ve-ptp(-/-) teratomas also show increased VEGF receptor-2 activity and loss of endothelial polarization. Moreover, the zebrafish VE-PTP orthologue ptp-rb is essential for polarization and lumen formation in intersomitic vessels. We conclude that the role of Tie2 in maintenance of vascular quiescence involves VE-PTP-dependent dephosphorylation of VEGF receptor-2, and that VEGF receptor-2 activity regulates VE-cadherin tyrosine phosphorylation, endothelial cell polarity and lumen formation.
  •  
8.
  • Lee, Husileng, et al. (författare)
  • An organic polymer CuPPc-derived copper oxide as a highly efficient electrocatalyst for water oxidation
  • 2020
  • Ingår i: Chemical Communications. - : ROYAL SOC CHEMISTRY. - 1359-7345 .- 1364-548X. ; 56:26, s. 3797-3800
  • Tidskriftsartikel (refereegranskat)abstract
    • Herein, we report a novel CuPPc (copper polymeric phthalocyanine)/CF (copper foam) nanoflake material, as precatalyst for the generation of an excellent water oxidation catalyst (WOC). Under optimized conditions, the CuPPc-derived Cu oxide affords a current density of 10 mA cm(-2) under an overpotential (eta) of 287 mV and sustains for at least 50 h in 1.0 M KOH. The strategy presented here is favorable to develop the electrocatalysts for water splitting.
  •  
9.
  • Lee, Husileng, et al. (författare)
  • Copper-based homogeneous and heterogeneous catalysts for electrochemical water oxidation
  • 2020
  • Ingår i: Nanoscale. - : Royal Society of Chemistry (RSC). - 2040-3364 .- 2040-3372. ; 12:7, s. 4187-4218
  • Forskningsöversikt (refereegranskat)abstract
    • Water oxidation is currently believed to be the bottleneck in the field of electrochemical water splitting and artificial photosynthesis. Enormous efforts have been devoted toward the exploration of water oxidation catalysts (WOCs), including homogeneous and heterogeneous catalysts. Recently, Cu-based WOCs have been widely developed because of their high abundance, low cost, and biological relevance. However, to the best of our knowledge, no review has been made so far on such types of catalysts. Thus, we have summarized the recent progress made in the development of homogeneous and heterogeneous Cu-based WOCs for electrochemical catalysis. Furthermore, the evaluations of catalytic activity, stability, and mechanism of these catalysts are carefully concluded and highlighted. We believe that this review can summarize the current progress in the field of Cu-based electrochemical WOCs and help in the design of more efficient and stable WOCs.
  •  
10.
  • Lee, Husileng, et al. (författare)
  • Hierarchical CoS2/Ni3S2/CoNiOx nanorods with favorable stability at 1 A cm(-2) for electrocatalytic water oxidation
  • 2019
  • Ingår i: Chemical Communications. - : ROYAL SOC CHEMISTRY. - 1359-7345 .- 1364-548X. ; 55:11, s. 1564-1567
  • Tidskriftsartikel (refereegranskat)abstract
    • Herein, we have reported an easily synthesized CoS2/Ni3S2/CoNiOx water oxidation catalyst with excellent catalytic activity and superior durability. The as-prepared catalyst required overpotential (eta) as low as 256 mV to exhibit a current density of 10 mA cm(-2) in 1.0 M KOH. Remarkably, it sustained a current density of 1 A cm(-2) for one week in 30% KOH solution with only 25 mV increment of eta. Thus, it is a hopeful candidate as a highly-effective water oxidation electrode in practical applications.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 25

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy